טוען...
The risk of vancomycin toxicity in patients with liver impairment
BACKGROUND: The influence of liver disease on the pharmacokinetic profile, the risk of acute kidney injury, and excessive drug exposure in patients treated with vancomycin was examined. METHODS: A retrospective cohort study was performed with patients discharged from a medical center between January...
שמור ב:
| הוצא לאור ב: | Ann Clin Microbiol Antimicrob |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7110653/ https://ncbi.nlm.nih.gov/pubmed/32234065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-020-00354-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|